Clinical Characteristics of Non-Melanoma Skin Cancers Recurring within 5 years after Mohs Micrographic Surgery: Single Institution Retrospective Chart Review
- PMID: 28936477
- PMCID: PMC5603292
- DOI: 10.13188/2373-1044.1000036
Clinical Characteristics of Non-Melanoma Skin Cancers Recurring within 5 years after Mohs Micrographic Surgery: Single Institution Retrospective Chart Review
Abstract
Background: Mohs micrographic surgery (MMS) is used to treat certain high-risk non-melanoma skin cancers (NMSC) due to its high cure rate. However, clinical recurrences do occur in a small number of cases.
Objective: We examined specific clinical characteristics associated with NMSC recurrences following MMS.
Methods: We employed a retrospective chart review of the 1467 cases of NMSC that underwent MMS at UC San Diego from January 1, 2008 through December 31, 2009. A total of 356 cases were excluded due to lack of follow-up.
Results: Five (0.45%) of 1111 cases developed recurrences of NMSC at the site of MMS. There were 741 cases of basal cell carcinomas (BCC); 3 were recurrences (0.40%). There were 366 cases of squamous cell carcinomas (SCC); 2 were recurrences (0.55%). Review of MMS histopathology of these recurrent tumors showed that there were no errors or difficulty with the processing or interpretation of the slides.
Conclusion: Five-year recurrence rate of NMSC following MMS at our institution is below the reported average. Our retrospective chart review identified specific clinical characteristics associated with NMSC recurrence including a history of smoking, anatomical location on the cheeks, ears or nose, and a history of immunosuppression for SCCs.
Figures
References
-
- Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, et al. Cancer statistics 2004. CA Cancer J Clin. 2004;54:8–29. - PubMed
-
- Stern RS. Prevalence of a history of skin cancer in 2007 results of an incidence-based model. Arch Dermatol. 2010;146:279–282. - PubMed
-
- Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol. 2007;156(Suppl 3):1–7. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials